Solid Tumor Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-14
Oct 14, 2021
V
Recruiting
  • Solid Tumor
  • +2 more
  • VSV-IFNβ-NIS
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic
2021-10-07
Oct 7, 2021
S
Active, not recruiting
  • Metastatic Cancer
  • Solid Tumor
  • Aurora, Colorado
  • +18 more
2021-10-13
Oct 13, 2021
M
Recruiting
  • Solid Tumor
  • Advanced Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
2021-10-13
Oct 13, 2021
S
Terminated
  • Cancer
  • +4 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    2021-10-13
    Oct 13, 2021
    T
    Recruiting
    • Solid Tumor
    • +3 more
    • Nashville, Tennessee
    • +2 more
    2021-10-06
    Oct 6, 2021
    M
    Not yet recruiting
    • Solid Tumor
    • +9 more
    • MEM-288 Intratumoral Injection
    • (no location specified)
    2021-09-29
    Sep 29, 2021
    U
    Recruiting
    • CNS Tumor
    • Solid Tumor
    • Nivolumab and Entinostat
    • Randwick, New South Wales, Australia
    • +11 more
    2021-10-12
    Oct 12, 2021
    M
    Recruiting
    • Solid Tumor
    • +2 more
    • CONVO intervention
    • New York, New York
    • +1 more
    2021-10-12
    Oct 12, 2021
    N
    Recruiting
    • Metastatic Prostate Cancer
    • +4 more
    • M7824
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-10-12
    Oct 12, 2021
    D
    Recruiting
    • Solid Tumor
    • Hematologic Malignancy
    • Chicago, Illinois
    • +2 more
    2021-10-05
    Oct 5, 2021
    S
    Completed
    • Metastatic Cancer
    • +2 more
    • Grand Rapids, Michigan
    • +3 more
    2021-10-11
    Oct 11, 2021
    H
    Active, not recruiting
    • Metastatic Cancer
    • +8 more
    • Tampa, Florida
      H Lee Moffitt Cancer Center and Research Institute
    2021-10-07
    Oct 7, 2021
    C
    Terminated
    • B Cell Lymphomas
    • +3 more
    • ACTR T Cell Product
    • Gilbert, Arizona
    • +15 more
    2021-10-04
    Oct 4, 2021
    C
    Recruiting
    • Endometrial Neoplasms
    • +3 more
    • COM701 in combination with BMS-986207 and nivolumab.
    • Chicago, Illinois
    • +6 more
    2021-10-03
    Oct 3, 2021
    E
    Recruiting
    • Solid Tumor
    • Kashiwa, Chiba, Japan
    • +10 more
    2021-10-01
    Oct 1, 2021
    P
    Recruiting
    • Solid Tumor
    • San Diego, California
      Rady Children's Hospital - San Diego
    2021-10-06
    Oct 6, 2021
    B
    Not yet recruiting
    • Solid Tumor
    • BNT141
    • Duarte, California
    • +3 more
    2021-09-30
    Sep 30, 2021
    M
    Recruiting
    • Rectal Adenocarcinoma
    • +4 more
    • Basking Ridge, New Jersey
    • +6 more
    2021-10-05
    Oct 5, 2021
    A
    Recruiting
    • Solid Tumor
    • Los Angeles, California
    • +6 more
    2021-10-04
    Oct 4, 2021